Philip Morris International, Inc. is a holding company engaged in the manufacturing and sale of cigarettes, tobacco, and nicotine-containing products. Its products include cigarettes and reduced-risk products, including heat-not-burn, vapor, and oral nicotine products, which are sold in markets outside the U.S. In its pursuit of working to deliver a smoke-free future, the company develops, scientifically substantiates, and commercializes smoke-free products for adults, who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Versions of PMI's IQOS Platform 1 devices and consumables have been authorized by the U.S. Food and Drug Administration as Modified Risk Tobacco Products (MRTPs), which are appropriate to promote the public health. It intends to expand into wellness and healthcare areas. The firm operates through the following geographical segments: the European Union, Eastern Europe, Middle East & Africa, South & Southeast Asia, East Asia & Australia, Americas, and Other. The company was founded by Philip Morris in 1847 and is headquartered in Stamford, CT.
NYSE
